Clinique La Croix du Sud
Quint-Fonsegrives, 31130, France
NCT Number: NCT05687019
The purpose of this study is to evaluate the score on urinary function (International Prostate Score Symptom) at 28 days.
The main objective is to assess the efficacy of treatment with Ialuril® Prefill on functional recovery at 4 weeks, based on the International Prostate Score Symptom.
A paired test will be performed to compare the International Prostate Score Symptom score between 0 and 28 days.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Quint-Fonsegrives, 31130, France
This is an interventional, non-comparative, open-label, monocentric study aimed at evaluating treatment with hyaluronic acid in patients who have undergone surgery (HOLEP procedure) for prostatic adenoma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5 injections of Ialuril® Prefill on D0 or D1, D7, D14, D21 and D28 after Holmium laser surgery for prostate adenoma
Time frame: 28 days
GCS Ramsay Santé pour l'Enseignement et la Recherche
Other
Efficacy of Hyaluronic Acid and Chondroitin Sulphate in Intravesical Injections on Functional Recovery After Holmium Laser Surgery for Prostate Adenoma (HOLEP-AHCS)
Acronym: HOLEP-AHCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04693507
Genital Diseases, Genital Diseases, Male
Kaunas, Lithuania
View Trial DetailsNCT02943070
Adenoma, Prostatic, Benign Prostatic Hyperplasia
Brno, Czechia
View Trial DetailsNCT02940392
Adenoma, Prostatic, Benign Prostatic Hyperplasia
La Romana, Dominican Republic
View Trial DetailsNCT07103278
Benign Prostatic Hyperplasia, Genital Diseases
Seoul, South Korea
View Trial Details